Delivery Order SPE2DR25D2206-SPE2DR26F9KR7
Award Date 1/12/26
Potential Completion Date 1/13/26
Potential Value $59K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $18,608.38 delivery order to AmerisourceBergen Drug Corp for 500 mg Dalvance vials, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that...
- The Defense Logistics Agency awarded a $2,688.81 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a specialty antibiotic used to treat bacterial skin infections. This firm fixed price delivery order, awarded on May 30, 2025, with completion expected by June 2, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,760.90 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic pharmaceutical product. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child delivery order, this award falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,145.80 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic medication used to treat bacterial skin infections. The contract is firm fixed price with no set-aside designation, reflecting open competition. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This award...
- The Defense Logistics Agency awarded a $29,398.41 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication used to treat bacterial infections. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order valued at $5,850.46 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Dalvance 500 mg vials, an antibiotic medication used to treat bacterial skin infections. This firm fixed price delivery order is set to be completed by January 6, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis without any set-aside designation, reflecting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 2, 2025, for the supply of Dalvance 500 mg vials with a contract ceiling value of $3,647.09. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and was funded through the Defense Logistics Agency's Medical Supply Chain. The award was made through competitive procurement with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $11,258.10 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic pharmaceutical product. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of October 31, 2025, and was issued on October 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves...
- The Defense Logistics Agency awarded a $11.6K delivery order (Contract No. 4569867824) to AmerisourceBergen Drug Corp for Dalvance 500 mg vials, a specialty antibiotic medication. The order was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of October 30, 2025. Performance will occur at the contractor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate headquarters as a leading...
- The Defense Logistics Agency awarded a $4,481.35 delivery order to AmerisourceBergen Drug Corp for 500 mg Dalvance vials on April 22, 2025, with a completion date of April 23, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. This delivery order falls under AmerisourceBergen's...